HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ayaka Tsuboi Selected Research

FHD

1/2022Serum Orosomucoid Is Associated with Serum Adiponectin, Adipose Tissue Insulin Resistance Index, and a Family History of Type 2 Diabetes in Young Normal Weight Japanese Women.
1/2022Association of family history of type 2 diabetes with blood pressure and resting heart rate in young normal weight Japanese women.
1/2022Elevated Blood Pressure (≥120/80 mmHg) Is Associated with Elevated Serum Plasminogen Activator Inhibitor-1, Low Birth Weight, and Family History of Diabetes in Young Normal Weight Japanese Women.
1/2022Reduced gluteofemoral (subcutaneous) fat mass in young Japanese women with family history of type 2 diabetes: an exploratory analysis.
1/2020Decreased arterial distensibility and postmeal hyperinsulinemia in young Japanese women with family history of diabetes.
1/2020Reduced Birth Weight, Decreased Early-Phase Insulin Secretion, and Increased Glucose Concentrations after Oral Glucose Tolerance Test in Japanese Women Aged 20 Years with Family History of Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ayaka Tsuboi Research Topics

Disease

19Insulin Resistance
04/2022 - 10/2014
17Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2013
11Inflammation (Inflammations)
01/2020 - 01/2013
5Birth Weight (Birth Weights)
04/2022 - 01/2020
3Obesity
01/2020 - 11/2015
3Chronic Renal Insufficiency
12/2019 - 01/2013
3Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2016 - 10/2014
2Albuminuria
12/2019 - 09/2017
2Anemia
05/2019 - 01/2013
2Hyperlipidemias (Hyperlipidemia)
01/2018 - 01/2017
2Body Weight (Weight, Body)
01/2018 - 01/2015
2Abdominal Obesity
09/2017 - 04/2017
1Periodontal Diseases (Periodontal Disease)
01/2023
1Diabetes Complications
01/2023
1Overweight
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Body-Weight Trajectory
01/2022
1Prediabetic State (Prediabetes)
10/2020
1Hyperinsulinism (Hyperinsulinemia)
01/2020
1Hypertriglyceridemia
01/2018
1Stomach Neoplasms (Stomach Cancer)
12/2017
1Stroke (Strokes)
04/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
04/2017
1Kidney Diseases (Kidney Disease)
02/2016
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2016
1Gallbladder Neoplasms (Gallbladder Cancer)
12/2015
1Autoimmune Pancreatitis
12/2015
1Cholecystitis
12/2015
1Necrosis
01/2015
1Malnutrition (Nutritional Deficiencies)
01/2015
1Dyslipidemias (Dyslipidemia)
10/2014
1Hematoma
12/2013
1Thoracic Aortic Aneurysm
12/2013
1Rupture
12/2013
1Airway Obstruction (Choking)
12/2013
1Vascular Diseases (Vascular Disease)
01/2013

Drug/Important Bio-Agent (IBA)

17AdiponectinIBA
01/2022 - 01/2013
13Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2015
9Insulin (Novolin)FDA Link
04/2022 - 01/2017
8LeptinIBA
01/2022 - 01/2015
7C-Reactive ProteinIBA
01/2022 - 01/2015
7AdipokinesIBA
01/2022 - 11/2015
6FHDIBA
01/2022 - 01/2020
6Triglycerides (Triacylglycerol)IBA
10/2021 - 10/2014
6CreatinineIBA
12/2019 - 01/2013
5Nonesterified Fatty Acids (NEFA)IBA
01/2022 - 01/2017
5HDL CholesterolIBA
10/2021 - 01/2015
4LipidsIBA
01/2022 - 01/2018
4Orosomucoid (Seromucoid)IBA
01/2022 - 01/2018
4Hemoglobins (Hemoglobin)IBA
12/2019 - 01/2015
3Prealbumin (Transthyretin)IBA
10/2021 - 01/2015
3LDL CholesterolIBA
01/2020 - 04/2017
3AlbuminsIBA
12/2019 - 01/2016
3CholesterolIBA
09/2017 - 02/2016
2Plasminogen Activators (Plasminogen Activator)IBA
10/2021 - 10/2014
2Plasminogen Activator Inhibitor 1IBA
10/2021 - 11/2015
2Acute-Phase Proteins (Acute-Phase Protein)IBA
10/2020 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2018 - 11/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 11/2015
2Lipoproteins (Lipoprotein)IBA
01/2018 - 01/2018
2Serum AlbuminIBA
01/2018 - 01/2015
2ApolipoproteinsIBA
01/2018 - 01/2018
2Cystatin CIBA
02/2016 - 01/2015
2Interleukin-6 (Interleukin 6)IBA
11/2015 - 10/2014
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
11/2015 - 10/2014
2CopperIBA
01/2015 - 01/2015
2IronIBA
01/2015 - 01/2013
1Proteins (Proteins, Gene)FDA Link
01/2022
1Alanine Transaminase (SGPT)IBA
01/2018
1ZincIBA
01/2018
1HDL LipoproteinsIBA
09/2017
1SymportersIBA
04/2017
1SodiumIBA
04/2017
1Fatty Acids (Saturated Fatty Acids)IBA
01/2017
1Immunoglobulins (Immunoglobulin)IBA
12/2015
1Immunoglobulin G (IgG)IBA
12/2015
1PlasminogenIBA
11/2015
1Indicators and Reagents (Reagents)IBA
01/2015
1Trace Elements (Biometals)IBA
01/2014

Therapy/Procedure

3Glycemic Control
01/2023 - 01/2015
2Endurance Training
01/2020 - 01/2017
1Gastrectomy
12/2017
1Stents
12/2013